Cormorant Asset Management, LP Adicet Bio, Inc. Transaction History

Cormorant Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$7.72 - $21.27 $6.18 Million - $17 Million	-800,000 Reduced 57.14%	600,000 $5.36 Million
Q3 2022 Nov 14, 2022	SELL	$13.43 - $18.74 $5.37 Million - $7.5 Million	-400,000 Reduced 22.22%	1,400,000 $19.9 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $10.8 Million - $21.9 Million	1,050,000 Added 140.0%	1,800,000 $26.3 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $5.53 Million - $13.1 Million	750,000 New	750,000 $13.1 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.